Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Cell Signal ; 120: 111241, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38825173

ABSTRACT

Cardiac fibroblasts (CF) are mesenchymal-type cells responsible for maintaining the homeostasis of the heart's extracellular matrix (ECM). Their dysfunction leads to excessive secretion of ECM proteins, tissue stiffening, impaired nutrient and oxygen exchange, and electrical abnormalities in the heart. Additionally, CF act as sentinel cells in the cardiac tissue microenvironment, responding to various stimuli that may affect heart function. Deleterious stimuli induce an inflammatory response in CF, increasing the secretion of cytokines such as IL-1ß and TNF-α and the expression of cell adhesion molecules like ICAM1 and VCAM1, initially promoting damage resolution by recruiting immune cells. However, constant harmful stimuli lead to a chronic inflammatory process and heart dysfunction. Therefore, it is necessary to study the mechanisms that govern CF inflammation. NFκB is a key regulator of the cardiac inflammatory process, making the search for mechanisms of NFκB regulation and CF inflammatory response crucial for developing new treatment options for cardiovascular diseases. SGK1, a serine-threonine protein kinase, is one of the regulators of NFκB and is involved in the fibrotic effects of angiotensin II and aldosterone, as well as in CF differentiation. However, its role in the CF inflammatory response is unknown. On the other hand, many bioactive natural products have demonstrated anti-inflammatory effects, but their role in CF inflammation is unknown. One such molecule is boldine, an alkaloid obtained from Boldo (Peumus boldus), a Chilean endemic tree with proven cytoprotective effects. However, its involvement in the regulation of SGK1 and CF inflammation is unknown. In this study, we evaluated the role of SGK1 and boldine in the inflammatory response in CF isolated from neonatal Sprague-Dawley rats. The involvement of SGK1 was analyzed using GSK650394, a specific SGK1 inhibitor. Our results demonstrate that SGK1 is crucial for LPS- and IFN-γ-induced inflammatory responses in CF (cytokine expression, cell adhesion molecule expression, and leukocyte adhesion). Furthermore, a conditioned medium (intracellular content of CF subject to freeze/thaw cycles) was used to simulate a sterile inflammation condition. The conditioned medium induced a potent inflammatory response in CF, which was completely prevented by the SGK1 inhibitor. Finally, our results indicate that boldine inhibits both SGK1 activation and the CF inflammatory response induced by LPS, IFN-γ, and CF-conditioned medium. Taken together, our results position SGK1 as an important regulator of the CF inflammatory response and boldine as a promising anti-inflammatory drug in the context of cardiovascular diseases.


Subject(s)
Aporphines , Fibroblasts , Immediate-Early Proteins , NF-kappa B , Protein Serine-Threonine Kinases , Signal Transduction , Animals , NF-kappa B/metabolism , Protein Serine-Threonine Kinases/metabolism , Immediate-Early Proteins/metabolism , Fibroblasts/metabolism , Fibroblasts/drug effects , Signal Transduction/drug effects , Rats , Aporphines/pharmacology , Inflammation/metabolism , Inflammation/pathology , Myocardium/pathology , Myocardium/metabolism , Cells, Cultured , Rats, Sprague-Dawley
2.
Carbohydr Polym ; 204: 170-181, 2019 Jan 15.
Article in English | MEDLINE | ID: mdl-30366529

ABSTRACT

Association constants and thermodynamicsparameters on inclusion of four 3-amido coumarins that present trypanocidal activity, into 6-amino-ß-cyclodextrin (1:1 stoichimetry) were determined. In addition, pure homopolymeric-α-l-guluronate fraction prepared by partial hydrolysis of sodium alginate from Sub-Antarctic Kelp Durvillaea antarctica was conjugated with 6-amino-ß-cyclodextrin (64% yield). To glycoconjugates, 3-amido coumarins were incorporated (73% of encapsulation) and supramolecular hydrogels were prepared by gelation with Ca2+ ions. The trypanocidal activity of the inclusion complexes increased by 10%. Likewise, an increase in diffusion in artificial membrane was observed (13%). It was found that the inclusion complexes increased the variation of the mitochondrial potential of T. cruzi (17%). The lowest release of substituted amidocoumarins (ACS) from supramolecular hydrogels occurred at pH 1.2 whereas the maximum release (34%) was observed at pH 8.0. Encapsulation of lipophilic bioactive compounds in supramolecular hydrogels allows the generation of release systems sensitive to pH with potential application in biomedicine.

3.
Carbohydr Polym ; 199: 304-313, 2018 Nov 01.
Article in English | MEDLINE | ID: mdl-30143133

ABSTRACT

This work is related to the structural characterization of the sulfated polysaccharide from Lessonia sp and the study of its antioxidant and antiparasitic properties. Sequential extraction afforded D-mannitol as the only low MW sugar alcohol. Extraction with 2% CaCl2 afforded in 3.0% yield, a sulfated fucan (SF). Its major fraction (48.5% yield), isolated by ion-exchange chromatography corresponds to a linear polymer of α-l-fucopyranosil residues linked 1→3, sulfated at the O-4 and partially at O-2 positions. By alkaline extraction, sodium alginate (10.3% yield) was obtained. The antioxidant capacity of SF by ESR showed high elimination index (IC50, mg/mL) of hydroxyl (0.27), alkoxy (10.05), and peroxyl (82.88) radicals in relation to commercial mannitol. SF showed activity against the epimastigote form of Trypanosoma cruzi parasite (250 µg/mL) and low cytotoxicity in murine cells (367 µg/mL). The elimination capacity of radicals in aqueous medium of SF would allow its potential biomedical application.


Subject(s)
Free Radical Scavengers/pharmacology , Polysaccharides/pharmacology , Sulfuric Acid Esters/pharmacology , Trypanocidal Agents/pharmacology , Animals , Carbohydrate Sequence , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Mice , Phaeophyceae/chemistry , Polysaccharides/chemistry , Polysaccharides/isolation & purification , RAW 264.7 Cells , Sulfuric Acid Esters/chemistry , Sulfuric Acid Esters/isolation & purification , Trypanocidal Agents/chemistry , Trypanocidal Agents/isolation & purification , Trypanosoma cruzi/drug effects
4.
Placenta ; 35(12): 1035-42, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25315217

ABSTRACT

INTRODUCTION: The congenital transmission of Trypanosoma cruzi (T. cruzi) is responsible for one-third of new Chagas disease cases each year. During congenital transmission, the parasite breaks down the placental barrier formed by the trophoblast, basal laminae and villous stroma. The observation that only 5% of infected mothers transmit the parasite to the fetus implies that the placenta may impair parasite transmission. The trophoblast undergoes continuous epithelial turnover, which is considered part of innate immunity. Therefore, we propose that T. cruzi induces differentiation in the trophoblast as part of a local antiparasitic mechanism of the placenta. METHODS: We analyzed ß-human chorionic gonadotropin (ß-hCG) and syncytin protein expression in HPCVE and BeWo cells using immunofluorescence and western blotting. Additionally, ß-hCG secretion into the culture medium was measured by ELISA. We assessed the differentiation of trophoblastic cells in BeWo cells using the two-color fusion assay and by determining desmoplakin re-distribution. RESULTS: T. cruzi trypomastigotes induce ß-hCG secretion and protein expression as well as syncytin protein expression in HPCVE and BeWo cells. Additionally, the parasite induces the trophoblast fusion of BeWo cells. DISCUSSION: T. cruzi induces differentiation of the trophoblast, which may contribute to increase the trophoblast turnover. The turnover could be a component of local antiparasitic mechanisms in the human placenta.


Subject(s)
Cell Differentiation , Chagas Disease/pathology , Placenta/parasitology , Trophoblasts/parasitology , Trypanosoma cruzi , Cell Line , Chagas Disease/metabolism , Chorionic Gonadotropin, beta Subunit, Human/metabolism , Female , Gene Products, env/metabolism , Humans , Placenta/metabolism , Placenta/pathology , Pregnancy , Pregnancy Proteins/metabolism , Trophoblasts/metabolism , Trophoblasts/pathology
5.
Phytomedicine ; 21(11): 1411-8, 2014 Sep 25.
Article in English | MEDLINE | ID: mdl-25022207

ABSTRACT

BACKGROUND: Chagas disease or American Trypanosomiasis is caused by the flagellated protozoan parasite Trypanosoma cruzi (T. cruzi) and is recognized by the WHO as one of the world's 17 neglected tropical diseases. Only two drugs (Benznidazol, Bz and Nifurtimox, Nx) are currently accepted for treatment, however they cause severe adverse effects and their efficacy is still controversial. It is then important to explore for new drugs. PURPOSE: Programmed cell death (PCD) in parasites offers interesting new therapeutic targets. The aim of this work was to evaluate the induction of PCD in T. cruzi by two natural sesquiterpene lactones (STLs), dehydroleucodine (DhL) and helenalin (Hln) as compared with the two conventional drugs, Bz and Nx. MATERIAL AND METHODS: Hln and DhL were isolated from aerial parts of Gaillardia megapotamica and Artemisia douglassiana Besser, respectively. Purity of compounds (greater than 95%) was confirmed by (13)C-nuclear magnetic resonance, melting point analysis, and optical rotation. Induction of PCD in T. cruzi epimastigotes and trypomastigotes by DhL, Hln, Bz and Nx was assayed by phosphatidylserine exposure at the parasite surface and by detection of DNA fragmentation using the TUNEL assay. Trypanocidal activity of natural and synthetic compounds was assayed by measuring parasite viability using the MTT method. RESULTS: The two natural STLs, DhL and Hln, induce programmed cell death in both, the replicative epimastigote form and the infective trypomastigote form of T. cruzi. Interestingly, the two conventional antichagasic drugs (Bz and Nx) do not induce programmed cell death. A combination of DhL and either Bz or Nx showed an increased effect of natural compounds and synthetic drugs on the decrease of parasite viability. CONCLUSION: DhL and Hln induce programmed cell death in T. cruzi replicative epimastigote and infective trypomastigote forms, which is a different mechanism of action than the conventional drugs to kill the parasite. Therefore DhL and Hln may offer an interesting option for the treatment of Chagas disease, alone or in combination with conventional drugs.


Subject(s)
Apoptosis/drug effects , Lactones/pharmacology , Sesquiterpenes/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Artemisia/chemistry , Chlorocebus aethiops , Molecular Structure , Nifurtimox/pharmacology , Nitroimidazoles/pharmacology , Sesquiterpenes, Guaiane , Vero Cells
6.
Curr Med Chem ; 21(15): 1757-71, 2014.
Article in English | MEDLINE | ID: mdl-24251576

ABSTRACT

In trypanosomatids, redox homeostasis is centered on trypanothione (N(1),N(8)-bis(glutathionyl)spermidine, T(SH)2), a low molecular weight thiol that is distinctive for this taxonomic family and not present in the mammalian host. Thus, the study of the metabolism of T(SH)2 is interesting as a potential therapeutic target. In this review, we summarize the existing evidence about the metabolism of thiols in Trypanosoma cruzi, focused on those proteins that can be considered the best candidates for selective therapy. Herein, we examine the biosynthetic pathway of T(SH)2, identifying three key points that are susceptible to attack pharmacologically: the activity of the trypanothione reductase (TR), the function of glutamate-cysteine ligase (GCL) and polyamine transport in T. cruzi. TR has been widely studied and is a good example for the development of the medicinal chemistry of antichagasic compounds. Conversely, GCL and the polyamine uptake system are high flow points in the reductive metabolism of the parasite. However, very little is known at the molecular level about these two systems. Therefore, their potential as targets for drug development is discussed, and it is suggested that research should focus on the production of alternative drugs for Chagas' disease treatment.


Subject(s)
Glutathione/analogs & derivatives , Polyamines/metabolism , Protozoan Proteins/metabolism , Spermidine/analogs & derivatives , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/metabolism , Animals , Glutathione/metabolism , NADH, NADPH Oxidoreductases/metabolism , Oxidation-Reduction , Spermidine/metabolism , Trypanosoma cruzi/drug effects
7.
Exp Parasitol ; 133(1): 114-20, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23178659

ABSTRACT

Dehydroepiandrosterone (DHEA) inhibits glucose 6-phosphate dehydrogenase (G6PDH) of different species and may potentially decrease intracellular glutathione. Therefore, it can have and enhance anti-parasitic action against Plasmodium spp. We evaluated the antiplasmodial activity and the interaction of DHEA with several antimalarial drugs. The inhibitory effect of DHEA on erythrocytic and G6PDH activity and changes in the content of total and reduced gluthatione Plasmodium falciparum content were also evaluated. DHEA showed antiplasmodial activity in vitro, but the potency was low (IC(50) 118.5 µM). DHEA inhibits G6PDH from healthy erythrocyte and decreases GSH content in both erythrocytes and P. falciparum. DHEA did not synergize or antagonize the antiplasmodial effect of several antimalarial drugs. The most important actions of DHEA were the inhibition of G6PDH activity, and the decrease in both P. falciparum and erythrocyte GSH. Since most of the GSH in Plasmodium spp. infected erythrocytes comes from the parasite itself, it is possible that DHEA analogs could act with higher selectivity, better potency, and might interact synergistically with antimalarials drugs.


Subject(s)
Antimalarials/pharmacology , Dehydroepiandrosterone/pharmacology , Plasmodium falciparum/drug effects , Adjuvants, Immunologic/pharmacology , Drug Synergism , Erythrocytes/drug effects , Erythrocytes/enzymology , Erythrocytes/metabolism , Glucosephosphate Dehydrogenase/antagonists & inhibitors , Glucosephosphate Dehydrogenase/blood , Glutathione/metabolism , Humans , Inhibitory Concentration 50 , Oxidation-Reduction , Plasmodium falciparum/metabolism , Schizonts/drug effects , Trophozoites/drug effects
8.
Placenta ; 33(12): 991-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23107342

ABSTRACT

BACKGROUND: Chagas' disease is caused by the haemophlagelated protozoan Trypanosoma cruzi (T. cruzi). During congenital transmission the parasite breaks down the placental barrier. In the present study we analyzed the participation of matrix metalloproteases (MMPs) in the extracellular matrix (ECM) remodeling during T. cruzi ex vivo infection of human placental chorionic villi explants. METHODS: Chorionic villi from healthy woman placentas were incubated in the presence or absence of 105 or 106 T. cruzi trypomastigotes (Y strain) with or without the MMPs inhibitor doxycycline. Effective infection was tested measuring parasite DNA by real time PCR (qPCR). MMP-2 and MMP-9 expression were determined by western blotting and immunohistochemistry and their activities were measured by zymography. The effect of MMPs on ECM structure was analyzed histochemically. RESULTS: T. cruzi induces the expression and activity of MMP-2 and MMP-9 in chorionic villi. Inhibition of the MMPs prevents the tissue damage induced by T. cruzi and partially decreases the ex vivo infection of the chorionic villi. CONCLUSION: MMPs are partially responsible for the ECM changes observed in human chorionic villi during T. cruzi infection and participate in tissue invasion. On the other hand, MMPs may be part of a local placental antiparasitic mechanism.


Subject(s)
Chagas Disease/immunology , Chorionic Villi/enzymology , Disease Resistance , Enzyme Induction , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 9/biosynthesis , Trypanosoma cruzi/immunology , Blotting, Western , Chagas Disease/pathology , Chagas Disease/prevention & control , Chagas Disease/transmission , Chorionic Villi/immunology , Chorionic Villi/parasitology , Chorionic Villi/pathology , DNA, Protozoan/metabolism , Doxycycline/pharmacology , Extracellular Matrix/immunology , Extracellular Matrix/metabolism , Extracellular Matrix/parasitology , Extracellular Matrix/pathology , Extracellular Matrix Proteins/metabolism , Female , Humans , Immunohistochemistry , Matrix Metalloproteinase 2/chemistry , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/chemistry , Matrix Metalloproteinase 9/metabolism , Pregnancy , Protease Inhibitors/pharmacology , Proteolysis/drug effects , Tissue Culture Techniques , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/isolation & purification , Trypanosoma cruzi/pathogenicity
9.
Placenta ; 32(5): 356-61, 2011 May.
Article in English | MEDLINE | ID: mdl-21420164

ABSTRACT

Chagas' disease, produced by the haemoflagellated protozoan Trypanosoma cruzi (T. cruzi), is one of the most frequent endemic diseases in Latin America. In spite that in the past few years T. cruzi congenital transmission has become of epidemiological importance, studies about this mechanism of infection are scarce. The placental tissue undergoes apoptosis throughout gestation, as part of its normal turnover. On the other hand, it is known that T. cruzi induces, delays or inhibits apoptosis in other mammalian tissues. In order to determine the effect of parasite invasion on normal apoptosis in the placenta, explants of human chorionic villi were incubated with 105 trypomastigotes for 24 h. Effective infection was tested by visualizing T. cruzi antigens in histological preparations and by PCR. Upon infection, apoptotic cell death was determined by light and transmission electron microscopy, TUNEL analysis, measurement of caspase-3 like activity and immunohistochemical detection of caspase 3 cleaved cytokeratin 18. Our results clearly show that T. cruzi induces apoptosis in the chorionic villi and suggest that this is one of mechanisms used by the parasite to insure infection and invasion of human placenta and fetus.


Subject(s)
Apoptosis , Chagas Disease/pathology , Chorionic Villi/pathology , Host-Parasite Interactions , Trypanosoma cruzi/physiology , Animals , Caspase 3/metabolism , Chagas Disease/metabolism , Chlorocebus aethiops , Chorionic Villi/parasitology , Coculture Techniques , DNA Fragmentation , Female , Humans , Keratin-18/metabolism , Pregnancy , Vero Cells
10.
Placenta ; 31(8): 705-11, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20541804

ABSTRACT

Congenital Chagas' disease, endemic in Latin America and also present with lower frequency in other countries, is associated with premature labor, miscarriage, and placentitis. The mechanism of tissue invasion and infection of human placenta by the parasite Trypanosoma cruzi (T. cruzi) remains unclear. In order to explore some morphological aspects of this infection in the placenta, we incubated chorionic villous explants from normal human placentae ex vivo with the parasite and studied the resulting effects by immunohistochemical and histochemical methods. Infection of the chorionic villi with the parasite was confirmed by immunofluoresence and PCR. T. cruzi induces syncytiotrophoblast destruction and detachment, selective disorganization of basal lamina and disorganization of collagen I in the connective tissue of villous stroma. These effects are a function of the number of parasites used for the infection. Our results suggest a participation of the proteolytic activity of the parasite on the placental basal lamina and connective tissue in the mechanism of infection of the fetus by T. cruzi.


Subject(s)
Chagas Disease/pathology , Chorionic Villi/pathology , Pregnancy Complications, Infectious/pathology , Trophoblasts/metabolism , Trypanosoma cruzi , Animals , Basement Membrane/metabolism , Chagas Disease/metabolism , Chlorocebus aethiops , Collagen Type I/metabolism , Connective Tissue/metabolism , Female , Humans , Pregnancy , Pregnancy Complications, Infectious/metabolism , Vero Cells
11.
Med Chem ; 4(1): 11-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18220967

ABSTRACT

In order to get insight into the trypanocidal mechanism of action of a series of 5-nitrofuryl containing thiosemicarbazones some studies related to their bioreduction were performed. Electron spin resonance spectra of radicals generated in T. cruzi by compounds' bioreduction were analyzed. Three different patterns of ESR signals were observed for the different assayed compounds. These results were in agreement with the changes in the T. cruzi-oxygen uptake promoted by these compounds. On the other hand, free-radical scavenger properties, measured as oxygen radical absorbance capacity (ORAC), did not seem to correlate with the trypanocidal activity.


Subject(s)
Nitrofurans/chemistry , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/pharmacology , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/pharmacology , Animals , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/chemical synthesis , Free Radical Scavengers/chemistry , Free Radical Scavengers/pharmacology , Humans , Oxidation-Reduction/drug effects , Oxygen Consumption/drug effects , Reactive Oxygen Species/metabolism , Thiosemicarbazones/chemistry , Trypanocidal Agents/chemistry , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/metabolism
12.
Exp Parasitol ; 99(1): 1-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11708828

ABSTRACT

Chagas' disease constitutes a therapeutic challenge because presently available drugs have wide toxicity to the host and are generally ineffective in the chronic stages of the disease. A series of oxazolo(thiazolo)pyridene derivatives were studied on Trypanosoma cruzi epimastigote growth and oxygen consumption and their electrochemical (redox) potentials and lipophilicity. The derivatives produced different degrees of parasite growth and respiration inhibition on CL Brener, LQ, and Tulahuen strains of T. cruzi epimastigotes. Respiratory chain inhibition appears to be a determinant of the trypanosomicidal activity of these compounds, since a significant correlation between respiration and culture growth inhibition was found. A similar correlation was found, within the different structural subfamilies, between toxic effects and the ability of the compounds to be oxidized in aqueous media. The inhibition of respiration and of parasite growth in culture increases with the lipophilicity of the substituents on the oxazolopyridine nucleus. No difference in the action of these derivatives was found among the different parasite strains. It is concluded that these compounds may have a potential usefulness in the treatment of Chagas' disease.


Subject(s)
Oxygen Consumption/drug effects , Pyridines/pharmacology , Trypanosoma cruzi/drug effects , Animals , Lipid Metabolism , Oxazoles/chemistry , Oxidation-Reduction , Pyridines/chemistry , Structure-Activity Relationship , Thiazoles/chemistry , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/metabolism
13.
Article in English | MEDLINE | ID: mdl-11790334

ABSTRACT

A series of 3-chloro-phenyl-1,4-dihydropyridine derivatives produced different degrees of inhibition of parasite growth and respiration on clone Brener, LQ and Tulahuen strains of Trypanosome cruzi epimastigotes. Respiratory chain inhibition appears to be a posible determinant of the trypanosomicidal activity of this compounds. No difference in the action of these derivatives was found among the different parasite strains. For comparative purposes, the inhibitory effects of felodipine and nicardipine are also reported. A good correlation between toxic effects and the easiness of oxidation of the dihydripyridine ring was found. The presence of a fused ring on the dihydropyridine moiety significantly diminished the inhibitory effects.


Subject(s)
Dihydropyridines/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Calcium Channel Blockers/pharmacology , Cell Movement/drug effects , Dihydropyridines/chemistry , Electrochemistry , Felodipine/pharmacology , Nicardipine/pharmacology , Oxidation-Reduction , Oxygen Consumption/drug effects , Trypanocidal Agents/chemistry , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/metabolism
15.
Article in English | MEDLINE | ID: mdl-8939007

ABSTRACT

Glutathione (GSH), trypanothione (T(SH)2) and glutathionyl spermidine (GSH-SP) concentrations were determined in the Tulahuén and LQ strains and the DM 28c clone of Trypanosoma cruzi. The concentrations of GSH, T(SH)2 and GSH-SP, expressed as nmol of GSH per g of parasite fresh weight, were 60.1, 397.8 and 103.9, respectively, for the Tulahuén strain. For the DM 28c clone, the values were 113.9, 677.9 and 164.1, respectively, and for the LQ strain they were 199.1, 1100.5 and 55.3, respectively. When the parasites were treated with 10 microM nifurtimox or 50 microM benznidazole for 2 h, the concentrations of all three reduced thiols decreased strongly. The total amount of T(SH)2 decreased by more than 50%. Treatment of the parasites with 5 mM buthionine sulfoximine, an inhibitor of GSH synthesis, for 6 h diminished the concentrations of the reduced thiols by between 27% and 53% with respect to the controls. Cyclohexylamine, an inhibitor of spermidine synthesis, decreased the concentrations of T(SH)2 and GSH-SP but not that of GSH. It is possible to conclude from this study that trypanothione is the most important thiol involved in the detoxication of nifurtimox and benznidazole in T. cruzi and that electrophilic reduced metabolites of both drugs are most probably conjugated with GSH, T(SH)2 and GSH-SP, thus decreasing their concentrations. GSH biosynthesis is an important drug target.


Subject(s)
Glutathione/analogs & derivatives , Glutathione/metabolism , Spermidine/analogs & derivatives , Trypanosoma cruzi/metabolism , Animals , Antimetabolites/pharmacology , Buthionine Sulfoximine/pharmacology , Cycloheximide/pharmacology , Glutathione/biosynthesis , Nifurtimox/pharmacology , Nitroimidazoles/pharmacology , Species Specificity , Spermidine/metabolism , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL